Research Interests
Dr. Glass received her BS in Neuroscience with Departmental Honors from the University of California at Los Angeles (UCLA) in 1997, before earning her MS from Baylor College of Medicine and MD from the University of Texas Medical Branch, Magna Cum Laude in 2007. Dr. Glass initially trained as a vascular surgeon with a focus on endovascular/interventional procedures through the Integrated Vascular Surgery Program at the University of Rochester Medical Center. As a recipient of the NIH National Lung Blood Institute T32 Ruth Kirschstein National Service Research Award, she completed a Ph.D with a concentration in Genomics and Epigenetics in 2014.
Selected Grants
NIH Recover: A Multisite Pathology Study of Post-Acute Sequelae of SARS-CoV2 Infection
ResearchPrincipal Investigator · Awarded by New York University · 2024 - 2026A digital polarization microscopy platform to enhance pathologist workflow
ResearchCo-Principal Investigator · Awarded by North Carolina Biotechnology Center · 2024 - 2026Improving Cardiac Transplant Outcomes Through PD-L1 Overexpression Gene Therapy
FellowshipCollaborator · Awarded by Thoracic Surgery Foundation for Research and Education · 2023 - 2025Epithelioid Mechanisms of Sarcoidosis
ResearchCollaborator · Awarded by Ann Theodore Foundation · 2022 - 2025Improving Cardiac Transplant Outcomes Through PD-L1 Overexpression Gene Therapy
FellowshipCollaborator · Awarded by American Heart Association · 2023 - 2024PSA level during midlife and undiagnosed prostate cancer at autopsy: Understanding tumor biology and racial disparities
ResearchCo Investigator · Awarded by Massachusetts General Hospital · 2022 - 2024Exploiting targeted therapy-induced ATM dependence in residual lung tumors
ResearchCollaborator · Awarded by Department of Defense · 2021 - 2023Turek - Step 2 Project
ResearchInvestigator · Awarded by Enzyvant · 2022 - 2023Diffraction tomography for accurate digital pathology on a portable microscope
ResearchPrincipal Investigator · Awarded by AiriLabs LLC · 2022 - 2023Identifying Epigenetic Biomarkers that Predict Response to Immunotherapy in Lung Cancer Patients
ResearchPrincipal Investigator · Awarded by Lung Cancer Initiative of North Carolina · 2020 - 2022Increasing the Diagnostic Accuracy of Antibody Mediated
Clinical TrialCo Investigator · Awarded by CareDx, Inc. · 2020 - 2021External Relationships
- College of American Pathologists
- North Carolina Biotechnology Center
- Ramona Optics Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.